dose of 125 mg/kg protected against 100 MICLD50. Oral treatment of VEE infection with analogue 11 ,567 24 h after subcutaneous inoculation of VEE virus resulted in no significant increase in the percentage of survivors. All survivors of these studies were susceptible to rechallenge 21 days after the first inoculation of virus.
Numerous substances induce interferon both in vitro and in vivo. Interferon inducers appear to be promising antiviral compounds for protection of humans and animals from viral infections (4, 5, 12) . Tilorone hydrochloride, the water-soluble dihydrochloride salt of 2,7-bis[2-(diethylamino)ethoxy]fluorene-9-one, is a low-molecular-weight, broad-spectrum, antiviral agent that presumably acts by inducing endogenous interferon (1, 10) . In mice, prophylactic oral administration of tilorone hydrochloride has been shown to be effective against vesicular stomatitis virus (VSV), mengovirus, encephalomyocarditis virus, influenza virus, and herpes simplex virus (8) . Intraperitoneal (i.p.) administration of tilorone is protective against the virus designated MM (3), and it is effective against Semliki forest virus when given by the oral, subcutaneous (s.c.), and i.p. routes (9) . Consequently, we have studied protection against Venezuelan equine encephalitis (VEE) virus in mice elicited by different prophylactic dosages of tilorone hydrochloride and three of its analogues given by either the oral or i.p. routes. In addition, results are presented of a preliminary therapeutic study with analogue 11,567 given by the oral route. Animals. Weanling outbred albino Swiss male mice (CD-1), weighing 14 to 20 g, were obtained from Charles River Mouse Farms, Inc., Wilmington, Mass. The mice were housed 4 to 6 per pan, fed, and given water ad libitum.
Virus. The Trinidad donkey strain of VEE virus was used in these studies (14) . The virus was originally isolated in guinea pigs and has been maintained by 13 lactically to VEE virus-infected mice. R. W. Krueger and S. Yoshimura (Fed. Proc. 29:635, 1970) reported that a single prophylactic dose of tilorone hydrochloride given 24 h before a lethal s.c. inoculation of Semliki forest virus provided maximal protection. Further, they reported the oral and i.p. mean lethal dose of tilorone to be 959 and 145 mg/kg, respectively. The most uniform increases in the percentage of survivors in the present studies occurred in mice given the compounds orally. When treatment was initiated 24 h after virus inoculation, analogue 11, 567 had no significant effect on survival. Consistent with these findings, others have shown that treatment of mice with the optimal oral dose of250 mg of tilorone hydrochloride per kg 24 to 48 h after a fatal challenge of Semliki forest virus did not significantly change the incidence of mortality (9) .
Although the antiviral activity of tilorone hydrochloride has been attributed to induction of interferon (1, 10), exceptions have been reported with several viruses. Giron et al. (3) reported that protection of mice with tilorone hydrochloride against MM virus is apparently not dependent on interferon induction. In their studies, circulating interferon was not detected with i.p. tilorone doses of less than 150 mg/kg. Others have reported that detectable interferon induced by pyran, polyriboinosinic acid * polyribocytidylic acid and bacterial endotoxin does not correlate with the degree of protection obtained by use of these agents against MM virus (13) and mengovirus (11) infections in mice.
Giron et al. (3) concluded that determination of circulating interferon concentration is of limited value in assessing antiviral activity, since protection can be demonstrated without the simultaneous detection of interferon. In contrast, others report that protection of mice against intranasal infection with VSV is directly related to the concentrations of interferon induced by different doses of tilorone (1). It appears that MM virus is much more susceptible to the action of tilorone, since lower doses of this compound that do not induce detectable amounts of circulating interferon are effective against MM virus but not against VSV (3).
Virulent Trinidad strain and attenuated TC-83 strain of VEE virus are sensitive to the antiviral activity of interferon (6) 
